Clinical Study Results
Research Sponsor: AstraZeneca
Drugs Studied: Adavosertib and olaparib
Study Title: A study to learn about the safety of adavosertib with olaparib
in participants with solid tumors or small-cell lung cancer
Thank you
Thank you for taking part in the clinical study for the study drug adavosertib
together with olaparib. Adavosertib is also called AZD1775. You and all the other
participants helped the researchers learn about using adavosertib and olaparib to
help people with solid tumors or small-cell lung cancer, also called SCLC.
AstraZeneca sponsored this study and thinks it is important to share the results. An
independent non-profit organization called CISCRP helped prepare this summary
of the study results for you.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
1